Loading...
Diabetic nephropathy: What does the future hold?
The consensus management of diabetic nephropathy (DN) in 2015 involves good control of glycaemia, dyslipidaemia and blood pressure (BP). Blockade of the renin–angiotensin–aldosterone system using angiotensin-converting enzyme inhibitors, angiotensin-2 receptor blockers or mineralocorticoid inhibitor...
Saved in:
| Published in: | Int Urol Nephrol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Springer Netherlands
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4705119/ https://ncbi.nlm.nih.gov/pubmed/26438328 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11255-015-1121-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|